The Retrofit: Lessons From Sotorasib's Dosing Conundrum

H Harpreet Singh P Paz J. Vellanki (Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD) R Richard Pazdur (From the Oncology Center of Excellence (G.U.M., R.P.) and the Office of the Commissioner (N.N.B., R.M.C.), Food and Drug Administration, Silver Spring, MD.)

Article Details

Volume / Issue Vol. 43, Issue 3
Published January 20, 2025
Pages 248-250
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (3)

H

Harpreet Singh

P

Paz J. Vellanki

Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD

R

Richard Pazdur

From the Oncology Center of Excellence (G.U.M., R.P.) and the Office of the Commissioner (N.N.B., R.M.C.), Food and Drug Administration, Silver Spring, MD.